By Anora Mahmudova and Carla Mozee, MarketWatch
NEW YORK (MarketWatch) -- After a choppy but mostly positive
morning, U.S. stocks turned south Wednesday afternoon, erasing
gains to trade lower on the day.
Defensive plays, such as utilities and consumer staples were
still attracting buyers amid broader market decline, suggesting
consolidation after sharp gains in the previous few sessions, that
had sent the S&P 500 to its best gain this year.
News of shots fired at the Canadian Parliament building in
Ottawa may be contributing to jittery markets.
The S&P 500 (SPX) slipped 7 points, or 0.4% to 1,934. The
Dow Jones Industrial Average (DJI) lost 90 points, or 0.5%, to
16,524, dragged down by big declines in Boeing Co. The Nasdaq
Composite (RIXF) slipped 18 points, or 0.4% to 4,401.66.
Colin Cieszynski, chief markets strategist at CMC Markets, in an
interview with MarketWatch said that shootings have created
uncertainty and are not helping markets that ran up over the past
three days and were looking for consolidation.
Cieszynski expects more volatility in the next few months. "I am
not convinced that the correction is over, we will probably retest
October lows, especially around the next Fed meeting and midterm
elections," he added.
In economic news, U.S. consumer prices rose slightly in
September owing to higher costs for food and housing, but
inflationary pressures continue to be held in check by falling
energy expenses. The uptick was in line with expectations.
Several heavyweights, including Boeing Co., Dow Chemical and
Biogen Idec Inc., reported before the opening bell.
Boeing (BA) shares fell 3.5% despite beating profit
expectations. RBC Capital Markets analyst Robert Stallard said that
while profit and revenue were better than expected, the aerospace
giant has encouraged investors to look at cash over EPS for the
best growth in the next few years. "..The lack of cash in 3Q, and
only a modest change to the operating cash guidance for the year
are likely to disappoint," he wrote in a note."
Dow Chemical (DOW) shares climbed 0.4% after the company's
adjusted third-quarter earnings of 72 cents a share came in above
the FactSet consensus estimate of 67 cents. Revenue also exceeded
analyst forecasts of $14.32 billion.
Biotech firm Biogen Idec (BIIB) reported better-than-expected
third-quarter results and lifted its full-year earnings outlook.
Shares had been up in premarket trade after the report, but later
dropped 7.3%.
Yahoo Inc. (YHOO) shares rose 5%, after the online search
provider posted better-than-expected third-quarter results late
Tuesday.
Stocks to watch: Tekmira Pharmaceuticals Corp. (TKMR) shares
popped up 11%, with the company saying it has started to limit
manufacturing of a new therapeutic drug targeting the Ebola virus.
Supply of the product will be available in early December 2014 "for
potential use by various collaborators," said Tekmira.
Tesla Motors Inc. (TSLA) fell 1.3% after Daimler AG on Tuesday
said it has sold its 4% stake in the electric car maker. (Read more
about the day's notable stocks in Movers & Shakers column:
http://www.marketwatch.com/story/tesla-boeing-yahoo-likely-to-see-action-wednesday-2014-10-22.)
Other markets: In Asia, Japanese stocks pushed higher, putting
the Nikkei Average up by 2.6%. European stocks and the euro
(EURUSD) retreated after a Spanish news report that 11 banks will
fail the European Central Bank's stress tests. The results are due
Sunday.
Gold futures (GCZ4) fell $6.4 an ounce and oil futures (CLZ4)
edged up. The dollar (USDJPY) traded slightly lower against the
yen.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires